Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 3/20 | 0.37 |
| ▸ | PPARA | Q07869 | 3/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | RAF1 | P04049 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.34 |
| ▸ | FABP4 | P15090 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5158853 | 0.86 | XDH (0.38) | SMN1; SMN2SLC22A12XDHNPSR1RAF1 | |
| SCHEMBL689748 | 0.80 | SMN1; SMN2 (0.54) | SMN1; SMN2PPARGPPARAFABP4 | |
| SCHEMBL5161670 | 0.80 | XDH (0.34) | PPARGXDHNPSR1RAF1ALDH1A1 | |
| SCHEMBL5158351 | 0.78 | SMN1; SMN2 (0.51) | SMN1; SMN2PPARGPPARAALDH1A1MAPT | |
| SCHEMBL5156106 | 0.78 | SMN1; SMN2 (0.51) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL12646435 | 0.78 | SMN1; SMN2 (0.58) | SMN1; SMN2PPARGPPARAALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL5162319 | 0.77 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL4277047 | 0.74 | SMN1; SMN2 (0.54) | SMN1; SMN2PPARGPPARAALDH1A1 | |
| SCHEMBL12695052 | 0.74 | CYP11B1 (0.51) | SLC22A12XDHRAF1GPR119EPAS1 | |
| SCHEMBL6112971 | 0.73 | SMN1; SMN2 (0.52) | SMN1; SMN2PPARGPPARAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070135468-A1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | SYNGENTA LIMITED (GB) | 2007-06-14 | — | — | US | disclosed |
| EP-1456174-B1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | SYNGENTA LTD (GB) | 2007-02-14 | — | — | EP | disclosed |
| US-7166621-B2 | Pyridyloxyalkanoic acid amide derivatives useful as fungicides | SYNGENTA LIMITED (GB) | 2007-01-23 | — | — | US | disclosed |
| US-20050065032-A1 | Pyridyloxyalkanoic acid amide derivatives useful as fungicides | SYNGENTA PARTICIPATIONS AG (CH) | 2005-03-24 | — | — | US | disclosed |
| EP-1456174-A1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | Syngenta Limited (GB) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003048128-A1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | SYNGENTA LIMITED (GB) | 2003-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065032-A1 | Pyridyloxyalkanoic acid amide derivatives useful as fungicides | DDT, C3AR1, CNPY3 | SMN1; SMN2 4129/4885SLC22A12 2504/4885PPARG 3196/4885 |
| US-20070135468-A1 | PYRIDYLOXYALKANOIC ACID AMIDE DERIVATIVES USEFUL AS FUNGICIDES | DDT, C3AR1, CBR3 | SMN1; SMN2 4082/4885SLC22A12 2554/4885PPARG 2869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.